Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2018; 8(11): 140-150


In-silico analysis of plant phytochemicals against Secreted Aspartic proteinase enzyme of Candida albicans

S. S. Meenambiga, R. Venkataraghavan, R. Abhishek Biswal.




Abstract

Candida albicans, a polymorphic fungal species of human microflora is pathogenic and are known to cause immense damage to the host organism which includes biofilm formation, oral and skin infections in immune deficient individuals. Secreted aspartic proteinase (Sap) enzyme plays a major role in promoting virulence to Candida albicans and thus could be established as a drug target for Candida infections. As a result, inhibiting the enzyme’s active center using phytochemicals would reduce the severity of the enzyme’s virulence. The present work focuses on the in-silico analysis of about 15 plant phytochemicals against the Sap enzyme using the AutoDock 4.2.6 software. The docking results were found to be promising with emodin having the highest binding score of -6.44 kCal/mol followed by the isoflavonoid equol with the binding score of -6.29 kCal/mol. Thus, these bioactive compounds could be used as leads for drugs targeting Sap enzymes in treating resistant Candida infections.

Key words: Candida albicans, Secreted aspartic proteinase (Sap), phytochemicals, In-silico, AutoDock.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.